Jennifer Humes
Förmögenhet: 4 M $ per 2026-08-31
Förmögenhet: 4 M $ per 2026-08-31
Jennifer Humes is Chief Accounting Officer at Roivant Sciences Ltd. and Roivant Sciences, Inc., starting in 2025.
Ms. Humes worked at JPMorgan Chase & Co. from 2016 to 2024, serving as Controller-Global Investment Banking in 2024.
Ms. Humes completed undergraduate education at the University of St. Thomas.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ROIVANT SCIENCES LTD. 0,02 % | 2026-06-20 | 109 782 ( 0,02 % ) | 4 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ROIVANT SCIENCES LTD. | Comptroller/Controller/Revisor | 2025-02-20 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Comptroller/Controller/Revisor | 2025-02-20 |
| Företag | Position | Slut |
|---|---|---|
| JPMORGAN CHASE & CO. | Företagsledare/Principal | 2024-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
JPMorgan Chase & Co.
JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
University of St. Thomas
University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån